OSE Immunotherapeutics SA

EPA:OSE.PA

7.5 (EUR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q32013 Q22013 Q1
Operating Activities:
Net Income -11.143-11.86-15.781-1.979-5.362-11.488-13.441-3.114-5.1660.514-3.3878.877-4.163-6.34-3.8424.506-2.642-2.942-2.18-0.655-0.127-0.064-0.123-0.062
Depreciation & Amortization 1.6961.8281.7741.671.7480.8440.3880.3420.2620.220.0560.060.0390.0840.0840.0230.0890.01000000
Deferred Income Tax -0.139-0.084-0.131-0.133-0.092-0.27400-0.1153.17800000000000000
Stock Based Compensation 0.4721.5621.9481.1821.0492.7241.1071.1761.1950.6730.4350.5420.9840.521-0.0670.7470.5141.34300.1350.006000
Change In Working Capital 0.303-1.138-2.037-1.105-0.9591.9840.249-3.442-0.4078.962-0.739-3.851-4.1417.397.97-7.6-0.747-0.2780.6430.12-0.02300.0320
Accounts Receivables 0.748-0.17-0.003-0.3660.038-0.34002.581-1.07500000000000000
Change In Inventory -1.0480000000-0.034000000000000000
Change In Accounts Payables -0.1230.882-5.0854.018-3.4752.796000.672-0.30900000000000000
Other Working Capital -0.322-1.853.051-4.7572.478-0.4720.249-3.442-3.62610.346-0.739-3.851-4.1417.397.97-7.6-0.747-0.2780.6430.12-0.02300.0320
Other Non Cash Items 4.0132.4718.48-0.6868.4411.4041.38-4.195-2.132.748-2.0761.16-1.368-1.002-0.902-20.237-0.0010.04-0.0010.0010.0250.001-0.0260.003
Operating Cash Flow -8.037-11.727-16.331-1.921-3.157-6.762-10.317-9.233-4.82713.798-5.7116.788-8.6490.6533.245-2.561-2.787-1.827-1.538-0.399-0.119-0.06-0.117-0.059
Investing Activities:
Investments In Property Plant And Equipment -0.0160-0.12-0.154-0.345-0.127-0.093-0.117-0.137-0.199-0.17-0.423-0.332-0.021-0.027-0.003-0.0430-0.02500000
Acquisitions Net -0.0620.06200-0.7920.7920000000003.16300000000
Purchases Of Investments -0.2750000.361-0.361000.104-0.10400000000000000
Sales Maturities Of Investments 00.0480.0960.2040-0.431002.8690.02600000000000000
Other Investing Activites -0.6010.110.0960.204-0.3550.4310.014-0.308-0.147-0.0370.0190.0160.06-0.0062.9210.051-5.772-0.142000000
Investing Cash Flow -0.6170.11-0.0240.05-1.1310.304-0.079-0.4252.689-0.314-0.151-0.407-0.272-0.0272.8943.211-5.815-0.142-0.0250.2790000
Financing Activities:
Debt Repayment -1.308-0.996-11.19-0.144-10.046-5.1950-6.599-4.65-0.5240-0.1810-2.120-0.4010-1.2060-0.00800-0.260
Common Stock Issued 11.170.4870.00600.0080.257000000000000000000
Common Stock Repurchased 000000000.019-0.019-0.025-0.042-0.062-0.005-0.046-0.052-0.142-0.179-0.08500000
Dividends Paid 000000000000000000000000
Other Financing Activities 12.3090.48610.782-0.51510.7680.09216.8440.1374.2090.046-0.298-0.0460.9930.01-0.283-0.452-0.28518.204-0.0062.8610.0710.0360.260.13
Financing Cash Flow 12.3091.01510.782-0.51510.6034.35416.8446.7364.4180.505-0.323-0.2690.9312.125-0.329-0.905-0.42719.231-0.0912.8690.0710.0360.260.13
Other Information:
Effect Of Forex Changes On Cash -0.00125.62-25.6233.579-33.57929.368-29.36825.842-25.8429.573-9.5739.646-9.64714.886-14.8859.33-9.3280.0010.008-0.0080000
Net Change In Cash 3.654-10.602-5.573-2.3866.315-2.1046.448-2.9222.2823.562-15.75815.758-17.63717.637-9.0759.075-18.35717.263-1.6462.741-0.351-0.0240.0720.072
Cash At End Of Period 18.67215.01825.6231.19333.57927.26429.36822.9225.8421.817015.758017.63709.075018.3571.0952.741-0.0240.3030.3270.072